Skandinaviska Enskilda Banken (SEB)’s Integra LifeSciences IART Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,645	Closed	-$575K	–	963
2022 Q2	$575K	Sell	10,645 -4,718	-31%	-$283K	﹤0.01%	787
2022 Q1	$987K	Sell	15,363 -7,626	-33%	-$502K	0.01%	755
2021 Q4	$1.57M	Hold	22,989	–	–	0.01%	700
2021 Q3	$1.57M	Sell	22,989 -1,363	-6%	-$96.3K	0.01%	705
2021 Q2	$1.66M	Buy	24,352 +695	+3%	+$49.1K	0.01%	714
2021 Q1	$1.63M	Buy	23,657 +351	+2%	+$23.8K	0.01%	715
2020 Q4	$1.51M	Buy	23,306 +6,379	+38%	+$343K	0.01%	728
2020 Q3	$799K	Buy	16,927 +16,545	+4,331%	+$787K	0.01%	769
2020 Q2	$18K	Buy	+382	New	+$18.8K	﹤0.01%	1023

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IART Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 10,645 shares — an estimated $575K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IART in Q2 2020 and held it in 9 quarters. The position peaked at $1.66M in Q2 2021. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

Skandinaviska Enskilda Banken (SEB) reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 10,645 Integra LifeSciences shares in Q3 2022, an estimated $575K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Integra LifeSciences in Q2 2020 and held it in 9 quarters.
Skandinaviska Enskilda Banken (SEB)'s Integra LifeSciences position peaked at $1.66M in Q2 2021.
282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.